Editorial draft — not for publication yet. Tramadol content needs review by a qualified UK healthcare professional before publication. For advice about your own prescription, contact your prescriber or pharmacist.

Quick answer

Tramadol is an opioid analgesic indicated in UK product information for moderate to severe pain. It may be considered when a clinician judges that the likely benefit outweighs risks for the individual; the kind of pain, its cause, other treatments, and medical history all matter.

When tramadol may be used for pain

Pain relief can be partial. If the pain is new, worsening, unexplained, or accompanied by worrying symptoms, assessment of the cause may be more important than simply increasing pain medicine.

Acute pain and persistent pain need different plans

For pain after an injury or procedure, the need for tramadol may change as recovery progresses. Ask how long it is intended for, when to review it, and what to do if pain remains severe or improves sooner than expected.

For pain lasting or recurring over time, NICE recommendations depend on whether it is chronic primary pain, neuropathic pain, or pain associated with a diagnosed condition. Do not assume an opioid is suitable indefinitely because it helped at first.

Standard and slow-release forms are not interchangeable

Standard tramadol is generally used for pain expected to last a shorter time; slow-release products provide medicine over a longer period and can take longer to begin working. The formulations have different instructions and schedules.

Use only the formulation and timing written on your prescription. Never crush, chew, or break a slow-release product unless its own leaflet specifically allows it. Ask a pharmacist to explain the difference if your supply changes.

Pain after an injury or procedure should be reassessed as it changes

A prescription written during a painful acute episode may not remain appropriate as the injury heals. Use the medicine for the duration and purpose on your label, attend the planned review, and ask what signs mean the pain needs reassessment.

If severe pain is not improving, becomes worse, or comes with fever, new weakness, or another concerning symptom, contact a healthcare professional. Do not increase tramadol just because the original plan is no longer controlling the pain.

Tramadol is one part of a pain plan

Depending on the cause, treatment may also involve care for the underlying condition, movement or rehabilitation, and other suitable pain-relief approaches. The clinician should explain what tramadol is intended to do and what benefit would justify continuing it.

Ask how long the prescription is intended to last, when it will be reviewed, what to do if you miss a dose, and how any regular use would be reduced. These questions are especially important if the pain lasts longer than expected.

Need help in the UK? Call 999 for a life-threatening emergency. For urgent medical advice that is not an emergency, contact NHS 111. Ask a pharmacist or prescriber about your specific medicine.

Frequently asked questions

What kind of pain is tramadol prescribed for?

UK product information indicates tramadol for moderate to severe pain. The cause, other treatment options, and personal risks determine whether it is suitable.

Is tramadol only for pain after surgery?

No. It can be prescribed for different types of moderate to severe pain, but the clinician decides whether it is appropriate and for how long.

Can I use an old tramadol prescription for new pain?

No. A new episode of pain may have a different cause or risk. Ask a clinician for advice and do not use medicine prescribed for an earlier problem without checking.

Should I keep taking tramadol after my injury starts to heal?

Follow your prescription and review plan. Ask your prescriber whether it is still needed and how to stop safely if you have been taking it regularly.

Sources and further reading

This page is based on the following UK sources. Check the leaflet supplied with your own product, as advice can differ between formulations.

Editorial status: Editorial draft — clinical review required before publication. Sources checked on 2 October 2026.

Related information

Read the Tramadol overview or continue to another topic: